Literature DB >> 35891728

Relationship between Oxidative Stress and the Blood Iron Concentration and Antioxidant Status in Major ß-thalassemia in Iraq.

R Salah Noori1, M Abdul-RedhaIsmaiel1.   

Abstract

Reduction or total lack of beta-globin chains caused by a congenital disease called ß-thalassemia major is one of the lives threatening diseases. Patients who suffer from ß-thalassemia need a repeated blood transfusion for survival. The repeated blood transfusion in ß-thalassemia patients may cause oxidative stress and tissue injury due to iron overload, altered antioxidant enzymes, and other essential trace element levels. The current study aimed to investigate the correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in ß-thalassemia major patients. A total of 130 serum samples were obtained from ß-thalassemia major patients (n=100; 50 males and 50 females) and healthy individuals (n=30; 15 males and 15 females). Hematological parameters were measured on both groups by a comprehensive blood test that included the amount of hemoglobin Hb, packed cells volume, number of red blood cells, mean corpuscular volume ratio, mean corpuscular hemoglobin ratio, mean corpuscular hemoglobin concentration, red cell distribution width, white blood cells, and platelets counts. All of these blood parameters showed a clear decrease in thalassemia patients, except for red blood cells and platelets counts, which demonstrated a significant increase. The highest significant mean for iron in males and females were 233.768 and 219.150 µgm\dL in patients, respectively, while the mean level of iron significantly reduced in the control group (113.40 and 103.33 µgm\dL in males and females, respectively). The results indicated a significant decrease in uric acid in males and females in the patient group (41.042 and 40.582 mg\L in males and females, respectively), compared to the control group (53.866 and 43.60 mg\L in males and females, respectively). Allantoin concentration was detected by high-performance liquid chromatography technique, the results of which showed that the highest values in patients were 62.822 and 25.480 mg\L in males and females, respectively, compared to the control group 2.342 and 1.481 mg\L in males and females, respectively. Superoxide dismutase concentration decreased in patients (129.635 and 111.848 U\mL in males and females, respectively), compared to the control group (208.623 and 190.413 U\ml in males and females, respectively).

Entities:  

Keywords:  Antioxidant; Beta-thalassemia; Superoxide dismutase; Trace elements; Uric acid\Allantoin

Mesh:

Substances:

Year:  2022        PMID: 35891728      PMCID: PMC9288602          DOI: 10.22092/ARI.2021.356536.1863

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  15 in total

Review 1.  Physiology and pathophysiology of heme: implications for kidney disease.

Authors:  Michal J Tracz; Jawed Alam; Karl A Nath
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

2.  Antioxidant status in children with homozygous thalassemia.

Authors:  Veena Dhawan; Kh Ratan Kumar; R K Marwaha; Nirmal K Ganguly
Journal:  Indian Pediatr       Date:  2005-11       Impact factor: 1.411

3.  Determination and separation of allantoin, uric acid, hypoxanthine, and xanthine by capillary zone electrophoresis.

Authors:  M Pizzichini; L Arezzini; C Billarelli; F Carlucci; L Terzuoli
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

4.  Evaluation of a kinetic uricase method for serum uric acid assay by predicting background absorbance of uricase reaction solution with an integrated method.

Authors:  Fei Liao; Yun-sheng Zhao; Li-na Zhao; Jia Tao; Xiao-yun Zhu; Lan Liu
Journal:  J Zhejiang Univ Sci B       Date:  2006-06       Impact factor: 3.066

5.  Antioxidant status in beta thalassemia major: a single-center study.

Authors:  Faiza Waseem; Karira A Khemomal; Raihan Sajid
Journal:  Indian J Pathol Microbiol       Date:  2011 Oct-Dec       Impact factor: 0.740

6.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

7.  Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

Authors:  Asma Kassab-Chekir; Sandrine Laradi; Selima Ferchichi; Amel Haj Khelil; Moncef Feki; Fathi Amri; Habib Selmi; Mohamed Bejaoui; Abdelhédi Miled
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

Review 8.  Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress.

Authors:  C Michiels; M Raes; O Toussaint; J Remacle
Journal:  Free Radic Biol Med       Date:  1994-09       Impact factor: 7.376

9.  High nontransferrin bound iron levels and heart disease in thalassemia major.

Authors:  Antonio Piga; Filomena Longo; Lorena Duca; Simona Roggero; Tiziana Vinciguerra; Roberto Calabrese; Chaim Hershko; Maria Domenica Cappellini
Journal:  Am J Hematol       Date:  2009-01       Impact factor: 10.047

10.  Total Antioxidant Status in Patients with Major β-Thalassemia.

Authors:  Fatemeh Bazvand; Sedigheh Shams; Mahtab Borji Esfahani; Lili Koochakzadeh; Maryam Monajemzadeh; Mohammad-Taghi Haghi Ashtiani; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2011-06       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.